Getinge AB (publ) (GNGBF)
USD 15.68
(0.0%)
USD 15.68
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 6.41 Billion SEK | 2.95% |
| 2022 | 6.23 Billion SEK | 30.73% |
| 2021 | 4.76 Billion SEK | 5.63% |
| 2020 | 4.51 Billion SEK | -3.79% |
| 2019 | 4.69 Billion SEK | 3.24% |
| 2018 | 4.54 Billion SEK | -6.87% |
| 2017 | 4.87 Billion SEK | -10.16% |
| 2016 | 5.43 Billion SEK | 0.41% |
| 2015 | 5.4 Billion SEK | 3.13% |
| 2014 | 5.24 Billion SEK | 23.3% |
| 2013 | 4.25 Billion SEK | 4.78% |
| 2012 | 4.06 Billion SEK | 5.81% |
| 2011 | 3.83 Billion SEK | 6.02% |
| 2010 | 3.61 Billion SEK | -12.92% |
| 2009 | 4.15 Billion SEK | 3.51% |
| 2008 | 4.01 Billion SEK | 37.83% |
| 2007 | 2.91 Billion SEK | 39.85% |
| 2006 | 2.08 Billion SEK | -3.41% |
| 2005 | 2.15 Billion SEK | 24.7% |
| 2004 | 1.72 Billion SEK | -1.94% |
| 2003 | 1.76 Billion SEK | 7.63% |
| 2002 | 1.63 Billion SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 7.21 Billion SEK | 1.25% |
| 2024 Q3 | 7.25 Billion SEK | 0.64% |
| 2024 Q1 | 7.12 Billion SEK | 11.02% |
| 2023 Q4 | 6.41 Billion SEK | -11.34% |
| 2023 Q1 | 6.78 Billion SEK | 8.91% |
| 2023 Q2 | 7.22 Billion SEK | 6.45% |
| 2023 Q3 | 7.23 Billion SEK | 0.17% |
| 2023 FY | 6.41 Billion SEK | 2.95% |
| 2022 Q4 | 6.23 Billion SEK | -3.62% |
| 2022 Q2 | 5.9 Billion SEK | 11.54% |
| 2022 Q1 | 5.29 Billion SEK | 11.1% |
| 2022 Q3 | 6.46 Billion SEK | 9.46% |
| 2022 FY | 6.23 Billion SEK | 30.73% |
| 2021 Q2 | 4.85 Billion SEK | 0.98% |
| 2021 FY | 4.76 Billion SEK | 5.63% |
| 2021 Q4 | 4.76 Billion SEK | -5.19% |
| 2021 Q3 | 5.02 Billion SEK | 3.63% |
| 2021 Q1 | 4.8 Billion SEK | 6.47% |
| 2020 Q4 | 4.51 Billion SEK | -21.34% |
| 2020 FY | 4.51 Billion SEK | -3.79% |
| 2020 Q1 | 5.46 Billion SEK | 16.39% |
| 2020 Q2 | 5.62 Billion SEK | 3.08% |
| 2020 Q3 | 5.73 Billion SEK | 1.94% |
| 2019 Q3 | 5.47 Billion SEK | 4.03% |
| 2019 Q2 | 5.26 Billion SEK | 3.1% |
| 2019 FY | 4.69 Billion SEK | 3.24% |
| 2019 Q1 | 5.1 Billion SEK | 12.3% |
| 2019 Q4 | 4.69 Billion SEK | -14.29% |
| 2018 Q2 | 5.68 Billion SEK | 1.77% |
| 2018 Q4 | 4.54 Billion SEK | -15.73% |
| 2018 FY | 4.54 Billion SEK | -6.87% |
| 2018 Q3 | 5.39 Billion SEK | -5.22% |
| 2018 Q1 | 5.59 Billion SEK | 14.57% |
| 2017 FY | 4.87 Billion SEK | -10.16% |
| 2017 Q1 | 6 Billion SEK | 10.57% |
| 2017 Q3 | 6.17 Billion SEK | -0.24% |
| 2017 Q2 | 6.18 Billion SEK | 3.05% |
| 2017 Q4 | 4.87 Billion SEK | -20.96% |
| 2016 Q4 | 5.43 Billion SEK | -11.53% |
| 2016 FY | 5.43 Billion SEK | 0.41% |
| 2016 Q3 | 6.13 Billion SEK | 4.12% |
| 2016 Q2 | 5.89 Billion SEK | 5.85% |
| 2016 Q1 | 5.57 Billion SEK | 2.98% |
| 2015 Q4 | 5.4 Billion SEK | -12.5% |
| 2015 FY | 5.4 Billion SEK | 3.13% |
| 2015 Q3 | 6.18 Billion SEK | 5.12% |
| 2015 Q2 | 5.88 Billion SEK | 0.22% |
| 2015 Q1 | 5.86 Billion SEK | 11.88% |
| 2014 Q2 | 5.06 Billion SEK | 9.03% |
| 2014 Q3 | 5.44 Billion SEK | 7.67% |
| 2014 Q4 | 5.24 Billion SEK | -3.74% |
| 2014 Q1 | 4.64 Billion SEK | 9.12% |
| 2014 FY | 5.24 Billion SEK | 23.3% |
| 2013 Q2 | 4.49 Billion SEK | 4.29% |
| 2013 Q1 | 4.31 Billion SEK | 6.23% |
| 2013 Q4 | 4.25 Billion SEK | -6.83% |
| 2013 FY | 4.25 Billion SEK | 4.78% |
| 2013 Q3 | 4.56 Billion SEK | 1.51% |
| 2012 Q2 | 4.29 Billion SEK | 6.73% |
| 2012 Q4 | 4.06 Billion SEK | -8.58% |
| 2012 FY | 4.06 Billion SEK | 5.81% |
| 2012 Q1 | 4.02 Billion SEK | 4.95% |
| 2012 Q3 | 4.44 Billion SEK | 3.33% |
| 2011 FY | 3.83 Billion SEK | 6.02% |
| 2011 Q4 | 3.83 Billion SEK | -11.3% |
| 2011 Q3 | 4.32 Billion SEK | 8.5% |
| 2011 Q2 | 3.98 Billion SEK | 5.36% |
| 2011 Q1 | 3.78 Billion SEK | 4.56% |
| 2010 Q1 | 4.24 Billion SEK | 2.24% |
| 2010 Q2 | 4.38 Billion SEK | 3.15% |
| 2010 Q4 | 3.61 Billion SEK | -10.53% |
| 2010 Q3 | 4.04 Billion SEK | -7.71% |
| 2010 FY | 3.61 Billion SEK | -12.92% |
| 2009 Q4 | 4.15 Billion SEK | 0.0% |
| 2009 FY | 4.15 Billion SEK | 3.51% |
| 2008 FY | 4.01 Billion SEK | 37.83% |
| 2007 FY | 2.91 Billion SEK | 39.85% |
| 2006 FY | 2.08 Billion SEK | -3.41% |
| 2005 FY | 2.15 Billion SEK | 24.7% |
| 2004 FY | 1.72 Billion SEK | -1.94% |
| 2003 FY | 1.76 Billion SEK | 7.63% |
| 2002 FY | 1.63 Billion SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AVITA Medical, Inc. | 3.12 Million USD | -205448.002% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | -4609.82% |
| QHSLab, Inc. | 25.18 Thousand USD | -25479428.216% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | -4609.82% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 1.61 Million USD | -397639.037% |
| Aurora Spine Corporation | 3.54 Million USD | -180932.143% |
| BrainsWay Ltd. | 3.71 Million USD | -172512.322% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 41.05 Thousand USD | -15628858.394% |
| Hamilton Thorne Ltd. | 14.36 Million USD | -44552.588% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 46.22 Thousand USD | -13879234.588% |
| REMSleep Holdings, Inc. | 99.14 Thousand USD | -6471099.33% |
| Zecotek Photonics Inc. | 94.9 Thousand USD | -6760700.843% |
| Avitar, Inc. | 225.15 Thousand USD | -2849479.847% |
| Nanomix Corporation | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 11.15 Million USD | -57395.583% |
| Theraclion SA | 3.05 Million EUR | -209936.58% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.25 Million USD | -510377.682% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 68.51 Thousand USD | -9363999.421% |
| Lombard Medical, Inc. | 6.87 Million USD | -93196.496% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 157.55 Million USD | -3972.34% |
| Vycor Medical, Inc. | 234.14 Thousand USD | -2740082.366% |
| Heart Tronics, Inc. | 163.85 Thousand USD | -3915533.239% |
| MicroPort Scientific Corporation | 414.75 Million USD | -1446.936% |
| VMS Rehab Systems, Inc. | 1.33 USD | -482406014937.594% |
| NewCardio, Inc. | - USD | -Infinity% |
| Guided Therapeutics, Inc. | 632 Thousand USD | -1015089.873% |
| Ingen Technologies, Inc. | 85.59 Thousand USD | -7495752.513% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 12.19 Thousand USD | -52633205.989% |
| Wellness Center USA, Inc. | 125.67 Thousand USD | -5104969.264% |
| SANUWAVE Health, Inc. | 2.95 Million USD | -217317.824% |
| IR-Med Inc. | -81.00 USD | 7920987754.321% |
| Perimeter Medical Imaging AI, Inc. | 128.99 Thousand USD | -4973581.967% |
| Polarean Imaging plc | 2.21 Million USD | -289080.303% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 313.4 Thousand USD | -2047065.206% |
| Medical Supply International USA, Inc. | 29.3 Thousand USD | -21893774.765% |
| Urologix, Inc. | 1.39 Million USD | -459169.864% |
| Rapid Therapeutic Science Laboratories, Inc. | 175.04 Thousand USD | -3665201.319% |
| Nexeon MedSystems Inc. | 2.2 Million USD | -290668.025% |
| SS Innovations International, Inc. | 6.32 Million USD | -101302.567% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | -168.27% |
| NIOX Group Plc | 6.11 Million USD | -104901.309% |
| Fuse Medical, Inc. | 9.11 Million USD | -70251.934% |
| Broncus Holding Corporation | 4.7 Million USD | -136186.722% |
| Brain Scientific Inc. | 149.55 Thousand USD | -4289874.458% |
| Pressure BioSciences, Inc. | 304.9 Thousand USD | -2104134.378% |
| Health Logic Interactive Inc. | -4511.80 USD | 142204984.968% |